ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2

Biochemical and Biophysical Research Communications

Volumn 396, Issue 4, 2010, Pages 927-932

  Tanabe, Chiaki ^a,b   Hotoda, Nika ^a   Sasagawa, Noboru ^a   Futai, Eugene ^a   Komano, Hiroto ^b   Ishiura, Shoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Secretase; ADAM19; Alzheimer's disease; CRIP2; Non classical secretion

Indexed keywords

ADAM PROTEIN; ADAM19 ENDOPEPTIDASE; BINDING PROTEIN; CYSTEINE RICH PROTEIN 2; EPIDERMAL GROWTH FACTOR; LIPOPOLYSACCHARIDE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOLYSIS; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; FETUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; SEQUENCE ANALYSIS; TWO HYBRID SYSTEM;

ADAM PROTEINS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME ACTIVATION; HUMANS; LIPOPOLYSACCHARIDES; PROTEIN STRUCTURE, TERTIARY; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77953289538     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.05.025     Document Type: Article

References (26)

1. Kang T., Zhao Y.G., Pei D., Sucic J.F., and Sang Q.X. Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J. Biol. Chem. 277 (2002) 25583-25591
2. Huovila A.P., Turner A.J., Pelto-Huikko M., Karkkainen I., and Ortiz R.M. Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30 (2005) 413-422
3. Edwards D.R., Handsley M.M., and Pennington C.J. The ADAM metalloproteinases. Mol. Aspects Med. 29 (2008) 258-289
4. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
5. Tanabe C., Hotoda N., Sasagawa N., Sehara-Fujisawa A., Maruyama K., and Ishiura S. ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells. Biochem. Biophys. Res. Commun. 352 (2007) 111-117
6. Kang T., Park H.I., Suh Y., Zhao Y.G., Tschesche H., and Sang Q.X. Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. J. Biol. Chem. 277 (2002) 48514-48522
7. Karim M.A., Ohta K., Egashira M., Jinno Y., Niikawa N., Matsuda I., and Indo Y. Human ESP1/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3. Genomics 31 (1996) 167-176
8. Wei P., Zhao Y.G., Zhuang L., Ruben S., and Sang Q.X. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta. Biochem. Biophys. Res. Commun. 280 (2001) 744-755
9. Zhang L., Hoffman J.A., and Ruoslahti E. Molecular profiling of heart endothelial cells. Circulation 112 (2005) 1601-1611
10. van Ham M., Croes H., Schepens J., Fransen J., Wieringa B., and Hendriks W. Cloning and characterization of mCRIP2, a mouse LIM-only protein that interacts with PDZ domain IV of PTP-BL. Genes Cells 8 (2003) 631-644
11. Wang X., Lee G., Liebhaber S.A., and Cooke N.E. Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J. Biol. Chem. 267 (1992) 9176-9184
12. Sadler I., Crawford A.W., Michelsen J.W., and Beckerle M.C. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J. Cell Biol. 119 (1992) 1573-1587
13. Kirchner J., Forbush K.A., and Bevan M.J. Identification and characterization of thymus LIM protein: targeted disruption reduces thymus cellularity. Mol. Cell Biol. 21 (2001) 8592-8604
14. Lanningham-Foster L., Green C.L., Langkamp-Henken B., Davis B.A., Nguyen K.T., Bender B.S., and Cousins R.J. Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1197-E1203
15. Tomczuk M., Takahashi Y., Huang J., Murase S., Mistretta M., Klaffky E., Sutherland A., Bolling L., Coonrod S., Marcinkiewicz C., Sheppard D., Stepp M.A., and White J.M. Role of multiple beta1 integrins in cell adhesion to the disintegrin domains of ADAMs 2 and 3. Exp. Cell Res. 290 (2003) 68-81
16. Iba K., Albrechtsen R., Gilpin B., Frohlich C., Loechel F., Zolkiewska A., Ishiguro K., Kojima T., Liu W., Langford J.K., Sanderson R.D., Brakebusch C., Fassler R., and Wewer U.M. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J. Cell Biol. 149 (2000) 1143-1156
17. Smith K.M., Gaultier A., Cousin H., Alfandari D., White J.M., and DeSimone D.W. The cysteine-rich domain regulates ADAM protease function in vivo. J. Cell Biol. 159 (2002) 893-902
18. Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H., Nievergall E., Blobel C.P., Himanen J.P., Lackmann M., and Nikolov D.B. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123 (2005) 291-304
19. Shirakabe K., Wakatsuki S., Kurisaki T., and Fujisawa-Sehara A. Roles of Meltrin beta /ADAM19 in the processing of neuregulin. J. Biol. Chem. 276 (2001) 9352-9358
20. Chesneau V., Becherer J.D., Zheng Y., Erdjument-Bromage H., Tempst P., and Blobel C.P. Catalytic properties of ADAM19. J. Biol. Chem. 278 (2003) 22331-22340
21. Kurohara K., Komatsu K., Kurisaki T., Masuda A., Irie N., Asano M., Sudo K., Nabeshima Y., Iwakura Y., and Sehara-Fujisawa A. Essential roles of Meltrin beta (ADAM19) in heart development. Dev. Biol. 267 (2004) 14-28
22. Komatsu K., Wakatsuki S., Yamada S., Yamamura K., Miyazaki J., and Sehara-Fujisawa A. Meltrin beta expressed in cardiac neural crest cells is required for ventricular septum formation of the heart. Dev. Biol. 303 (2007) 82-92
23. Sun X., Zhang R., Lin X., and Xu X. Wnt3a regulates the development of cardiac neural crest cells by modulating expression of cysteine-rich intestinal protein 2 in rhombomere 6. Circ. Res. 102 (2008) 831-839
24. McGeer P.L., Schulzer M., and McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47 (1996) 425-432
25. Baum L., Hansen L., Masliah E., and Saitoh T. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Mol. Chem. Neuropathol. 29 (1996) 253-261
26. Alvarez A.R., Godoy J.A., Mullendorff K., Olivares G.H., Bronfman M., and Inestrosa N.C. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. 297 (2004) 186-196